Home / News (Page 2)

News

Invectys at the AACR meeting in Atlanta, March 2019

Invectys will be attending the AACR Annual Meeting 2019, March 29 – Apr 3, 2019. Georgia World Congress Center Atlanta,  The AACR (American Association for…

Read more

Invectys secures €15 million equity financing

Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL   Financing complements the…

Read more

Invectys at JP Morgan 37th Annual Healthcare Conference...

January 7 – 10, 2019 J.P. Morgan 37th Annual Healthcare Conference 2019 San-Francisco   The annual J.P. Morgan Healthcare Conference is the largest and most…

Read more

FDA approval to launch INVAC-1 Phase II clinical trial

Invectys announces FDA approval to launch a Phase II clinical trial of its therapeutic cancer vaccine INVAC-1 After a recent capital raise of 4.3 M€s another…

Read more

4,3 Millions d’Euros de levés pour initier la Phase II

After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines   Paris, July 12th, 2017 – This round brings…

Read more

Invectys presents its INVAC-1 therapeutic vaccine Phase...

Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…

Read more

Invectys at the Third International Symposium on Immuno...

Invectys at the Third International Symposium on Immunotherapy organised by The Institute for Cancer Vaccines & Immunotherapy (previously known as the Cancer…

Read more

Invectys at ASCO 2017 in Chicago : Clinical Oncology

Invectys attend ASCO 2017 meeting in Chicago  Invectys will be at the Annual Meeting is organized by American Society Of Clinical Oncology (ASCO). This meeting…

Read more